CEO Chris Kempczinski received around $10.8m in total pay last year. He earned $963,500 in base salary, down from almost $1.3m after the fast-food giant cut executive salaries between April and October due to the pandemic affecting sales, says CNBC. However, like most CEOs of publicly traded companies, the bulk of Kempczinski’s pay is in the form of stock awards, worth $9.5m. Extras, including the use of the firm’s private plane, accounted for $383,300.


Jeff Miller, CEO, earned roughly $10m more in 2020 than the previous year, “despite company pledges to reduce executive pay as the Coronavirus pandemic crushed the oil industry”, says Reuters. He earned $22.3m for last year against $12.8m in 2019. While his base salary declined by $200,000 from a year earlier, he received $9.7m in stock awards, versus $3.6m in 2019. His compensation for last year was 293 times that of the median pay for his employees.


Professor Sarah Gilbert, the woman behind Oxford University’s Covid-19 vaccine, developed with AstraZeneca, is set to land a payday of $12.5m-$19.5rh after her biotech start-up Vaccitech filed for a blockbuster US listing, expected for later this year, says The Daily Telegraph. Gilbert holds almost 3 of the shares in the company that raised $168m earlier this year in funding found that valued Vaccitech at $450m. The biotechs hoping for a valuation of $700m in the float.


Kris Paterson is a writer for